nvs
☆    

India,
2008-02-19 08:11
(5883 d 06:16 ago)

(edited by Ohlbe on 2008-02-19 21:46)
Posting: # 1621
Views: 2,961
 

 Type of studies etc. [Dissolution / BCS / IVIVC]

Dear all,
Anybody let me know about flow for in-vitro studies, In which stage of drug designing we have to take approval for in-vitro studies for both innovative & generic drugs.
Which parameters we have to do?
Do we conduct in-vitro studies separately with different mechanism (different in-vitro parameters) for generic & innovative drugs.
What are the common parameters for generic & innovative drugs (in in-vitro studies)
pz share any guidelines regarding this.

--
Edit: Category changed. [Ohlbe]
Edit: Subject line altered. [Helmut]
UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
117 visitors (0 registered, 117 guests [including 12 identified bots]).
Forum time: 14:28 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5